In the high-shear environment found in the microvasculature or stenosed arteries, the adhesion of platelets critically depends on interactions with the plasma glycoprotein von Willebrand factor (VWF).

A team of researchers is working to characterize the mysterious protein known as the Von Willebrand Factor (vWF ... in part by National Science Foundation grant DMS-1463234 and utilized the ...

Wheat production is essential for global food security, and continual improvement to grain yield is necessary to meet the nutritional demands of the expanding human population. Grain size is ...

"Mark's analysis by mass spectrometry displays a lot of the details about the composition of normal human plasma von Willebrand factor ... from the National Science Foundation's (NSF) Biological ...

and new treatment regimens that will take into account the individual characteristics of the human body associated with von Willebrand factor. More information: Anna Yi. Aksenova, von Willebrand ...

Willfact ® (pure human von Willebrand factor (vWF) concentrate) was launched in Germany in May 2010 for the prevention and treatment of haemorrhages or surgical bleeding in von Willebrand Disease ...

Research by RCSI University of Medicine and Health Sciences has discovered a new role for the blood clotting protein, von Willebrand Factor (VWF ... National Hemophilia Foundation (NHF), and ...

Findings showed that routine prophylaxis with wilate resulted in an 84% reduction in mean total ABRs compared with on-demand treatment. The Food and Drug Administration (FDA) has expanded the ...

Supported by grants from the Wimpfheimer Foundation and the John A. Hartford Foundation, Incorporated. We are immeasurably indebted to the many women and their physicians who co-operated ...

The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for ... within the U.S. Department of Health and Human Services, protects the public health ...